Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

From Denial of Spondyloarthritis to a Support Group Leader & Medical Doctor of Rheumatology: A Patient’s Perspective

Shung Ming Chiu, MD  |  November 29, 2022

PHILADELPHIA—“My symptoms started in the final year of medical school, and at that stage I believed I was strong enough to fight my condition,” said Shung Ming Chiu, MD, in a poster presentation at ACR Convergence 2022. “Later, I realized that it’s not [about] fighting [but] rather accepting it and adapting to the new normal. The biggest challenge I faced was balancing between the good and the bad days, to not overexert on good and strive on bad days—all of it during my final exams in winter.”

Poster Presentation for ACR Convergence by Dr. Shung Chiu

 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Chiu’s story:

From being a table tennis champion to getting into medical school, I thought my life was smooth sailing. But little did I know it was all going to change.

In February 2018, the day before I turned 22, I started experiencing back pain, fever and diarrhea. The fever and diarrhea resolved in three days, but the pain remained and progressed over the next two months—leaving me bedridden.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

My doctor suspected spondyloarthritis (SpA). After the HLA-B27 blood test came back positive and an MRI of my spine showed changes, I was prescribed Etoricoxib, a non-steroidal anti-inflammatory drug (NSAID) followed by sulfasalazine, a disease-modifying anti-rheumatic drug (DMARD). However, they provided only partial relief.

Unconvinced and in search of an alternate diagnosis, I underwent a series of inconclusive medical visits with different doctors and investigations, only to arrive at a dead end. Several diagnoses and medications left me more confused and distraught. All this happened during the last year of medical school. When my colleagues were preparing to embark upon their careers, I was in fear of my future uncertainties, questioning whether I would ever get better.

Desperate for a cure, I tried everything—alternative medicine, physiotherapy and low-impact exercises, such as swimming, cycling and the use of orthotics, but nothing worked. Losing all hope I had spiraled to my lowest point.

I decided to take a break from my studies, and with the help of my family, I went to stay with relatives abroad. The trip made me realize that the world had much to offer, and I shouldn’t waste it self-pitying.

With a new perspective, I was determined to get better. Luckily, I eventually found a doctor who understood my predicament and helped me accept my diagnosis of SpA. From that day onward, I never looked back. I understood my limitations and set my expectations accordingly. With the same medications and exercise routine, I showed more improvement. Slowly and steadily, I got back into my medical training and became a doctor.

In retrospect, I realize that accepting my diagnosis was the hard part. …

I am now a member of the Spondylitis Association of America and its first International Support Group Leader, hoping to inspire people like me to live their best life. I am also working as a medical officer in rheumatology under the leadership of the same doctor who guided me through my SpA journey.

 

Share: 

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting ReportsOpinionPatient PerspectiveSpeak Out Rheum Tagged with:ACR Convergence 2022ACR Convergence 2022 – ASpatient perspective

Related Articles

    The Classification Challenge of Pediatric Spondylarthritis

    April 1, 2010

    Condition often confused with other disorders

    Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

    April 2, 2014

    Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA

    Rheumatology Research Foundation’s Annual Investigators’ Meeting Spotlights Latest Findings

    October 1, 2014

    Groundbreaking research in treatments for rheumatoid arthritis, inflammatory disease discussed at Foundation’s celebrated event

    New Diagnostic Criteria for Axial Spondylarthritis

    February 3, 2012

    New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences